Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: a report of two cases and review of the literature

Therapeutic Advances in Endocrinology and Metabolism

Volumn 8, Issue 1-2, 2017, Pages 14-19

  Bishay, Ramy H ^a   Ganda, Kirtan ^a,b   Seibel, Markus J ^a,b  

^a ANZAC Research Institute   (Australia)

^b University of Sydney   (Australia)

Author keywords

fracture; hypophosphataemia; iron infusion; osteomalacia

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; CALCIUM CARBONATE; COLECALCIFEROL; EPROSARTAN; ESCITALOPRAM; ESOMEPRAZOLE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; FLUTICASONE PROPIONATE PLUS SALMETEROL XINAFOATE; IPRATROPIUM BROMIDE; IRON POLYMALTOSE; PHOSPHATE; TRANEXAMIC ACID;

ADULT; AGED; BONE DENSITY; BONE DEVELOPMENT; BONE PAIN; CASE REPORT; COMPRESSION FRACTURE; DUAL ENERGY X RAY ABSORPTIOMETRY; EMPHYSEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GLOMERULUS FILTRATION RATE; HUMAN; HYPOPHOSPHATEMIA; HYPOPHOSPHATEMIC RICKETS; IRON DEFICIENCY ANEMIA; KIDNEY TUBULE ABSORPTION; METABOLIC BONE DISEASE; MIDDLE AGED; MULTIPLE FRACTURE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOMALACIA; PHOSPHATURIA; PRIORITY JOURNAL; REVIEW; SPINE FRACTURE; STOMACH ANTRUM VASCULAR ECTASIA; TELANGIECTASIA;

EID: 85011663114     PISSN: 20420188     EISSN: 20420196     Source Type: Journal    
DOI: 10.1177/2042018816678363     Document Type: Review

References (18)

1. Bingham C., Fitzpatrick L., (1993) Noninvasive testing in the diagnosis of osteomalacia. Am J Med 95: 519–523.
2. Blazevic A., Hunze J., Boots J., (2014) Severe hypophosphataemia after intravenous iron administration. Neth J Med 72: 49–53.
3. Bregman D., Goodnough L., (2014) Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia. Ther Adv Hematol 5: 48–60.
4. Chong W., Molinolo A., Chen C., Collins M., (2011) Tumor-induced osteomalacia. Endocr Relat Cancer 18: R53–R77.
5. Favrat B., Balck K., Breymann C., Hedenus M., Keller T., Mezzacasa A.. (2014) Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women—PREFER a randomized, placebo-controlled study. PLoS One 9: e94217.
6. Fierz Y., Kenmeni R., Gonthier A., Lier F., Pralong F., Coti Bertrand P., (2014) Severe and prolonged hypophosphatemia after intravenous iron administration in a malnourished patient. Eur J Clin Nutr 68: 531–533.
7. Hardy S., Vandemergel X., (2015) Intravenous iron administration and hypophosphatemia in clinical practice. Int J Rheumatol 2015: 468675.
8. Hussain I., Bhoyroo J., Butcher A., Koch T., He A., Bregman D., (2013) Direct comparison of the safety and efficacy of ferric carboxymaltose versus iron dextran in patients with iron deficiency anemia. Anemia 2013: 169107.
9. Okada M., Imamura K., Fuchigami T., Omae T., Iida M., Nanishi F.. (1982) [2 cases of nonspecific multiple ulcers of the small intestine associated with osteomalacia caused by long-term intravenous administration of saccharated ferric oxide]. Nihon Naika Gakkai Zasshi 71: 1566–1572.
10. Payne R., (1998) Renal tubular reabsorption of phosphate (TmP/GFR): indications and interpretation. Ann Clin Biochem 35: 201-206.
11. Rector’s B., (2012) Phosphate transport. In: Al M., (ed.), The Kidney. Philadelphia, PA: Elsevier Saunders.
12. Renkema K., Alexander R., Bindels R., Hoenderop J., (2008) Calcium and phosphate homeostasis: concerted interplay of new regulators. Ann Med 40: 82–91.
13. Schouten B., Hunt P., Livesey J., Frampton C., Soule S., (2009) FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study. J Clin Endocrinol Metab 94: 2332–2337.
14. Shimada T., Hasegawa H., Yamazaki Y., Muto T., Hino R., Takeuchi Y.. (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19: 429–435.
15. Shimizu Y., Tada Y., Yamauchi M., Okamoto T., Suzuki H., Ito N.. (2009) Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. Bone 45: 814–816.
16. Sommer S., Berndt T., Craig T., Kumar R., (2007) The phosphatonins and the regulation of phosphate transport and vitamin D metabolism. J Steroid Biochem Mol Biol 103: 497–503.
17. Van Wyck D., Mangione A., Morrison J., Hadley P., Jehle J., Goodnough L., (2009) Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion 49: 2719–2728.
18. Wolf M., Koch T., Bregman D., (2013) Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 28: 1793–1803.